|
 |
 |
 |
Obesity: Reviving the promise of leptin
January 07, 2009
The first known leptin-sensitizing agents induce mice to lose weight The discovery more than a decade ago of leptin, an appetite-suppressing hormone secreted by fat tissue, generated headlines and great hopes for an effective treatment for obesity. But hopes dimmed when it was found that obese people are unresponsive to leptin due to development of leptin resistance in the brain. Now, researchers at Children's Hospital Boston report the first agents demonstrated to sensitize the brain to leptin: oral drugs that are already FDA-approved and known to be safe. Findings were published January 7 by the journal Cell Metabolism. In 1995, researchers reported in Science that they had isolated a protein that is present in normal mice, but not in an obese strain of mice called ob/ob, which lacked a gene also called ob. When either obese or normal mice were directly injected with the protein - now called leptin - they ate less and lost weight. "Everyone in the field thought they would get the Nobel," says Umut Ozcan, MD, of Children's Division of Endocrinology. Unfortunately, when obese humans took the hormone, they lost weight only temporarily - then rebounded back. "Most humans who are obese have leptin resistance," says Ozcan. "Leptin goes to the brain and knocks on the door, but inside, the person is deaf." For years, industry and academic laboratories have been searching for a drug to make peoples' brains sensitive to leptin again, without success. In the new study, Ozcan's group first showed that the brain cells of obese mice have increased stress in the endoplasmic reticulum (ER) - a structure within the cell where proteins are assembled, folded into their appropriate configurations, and dispatched to do jobs for the cell. In the presence of obesity, the ER is overwhelmed and can't function properly. This stress triggers a signaling cascade (the "unfolded protein response") that tries to relieve the stress by increasing the level of molecular "chaperones," which assist in protein folding, and by blocking more proteins from coming in. Ozcan and colleagues then showed that ER stress, and the resulting activation of this signaling cascade, blocks leptin action in the brain. Most intriguingly, they showed that using chemical chaperones to reduce ER stress can re-sensitize the brain to leptin, and lead to weight loss when used in conjunction with leptin. "I think our study will bring new hope for the treatment for obesity," says Ozcan. Working first with mice made obese through a high-fat diet, they demonstrated that the animals developed ER stress in the hypothalamus, the main area of the brain where leptin signals. This in turn initiated the unfolded-protein response, rendering the mice extremely leptin-resistant. The team also created a strain of mice whose ER was weakened in the brain through deletion of a gene called XPB1 specifically in the neurons. These mice also developed ER stress and leptin resistance, and also became obese, despite having some of the highest leptin levels ever reported. As expected, the mice also ate more and gained more weight. But when Ozcan and colleagues pretreated either group of mice with a chemical chaperone (either 4-PBA or TUDCA) leptin sensitivity increased as much as 10-fold, and the mice had significant weight loss with leptin treatment even when fed a high-fat diet. Children's researchers hope to eventually move the discovery to human trials. Both 4-PBA and TUDCA are safe in humans and already FDA-approved for clinical use. 4-PBA (Buphenyl) used in urea cycle disorders and in cystic fibrosis; TUDCA (tauroursodeoxycholic acid), used for centuries in traditional Chinese medicine, is currently used in some liver diseases. Both agents are under study for use in neurologic disorders such as Alzheimer's disease and Huntington's disease. In related work in 2006, Ozcan and colleagues reported in Science that chemical chaperones reduce ER stress in a mouse model of type 2 diabetes, normalizing blood sugar and restoring insulin sensitivity. In 1995, Amgen, Inc. (Thousand Oaks, CA) paid $20 million for commercial rights to recombinant human leptin, a record amount for a deal with an academic institution. In 2006, Amgen sold the rights to Amylin Pharmaceuticals (San Diego, CA). Amylin is testing leptin in combination with its diabetes drug, pramlintide. Children's Hospital Boston

|
The Obesity Epidemic: What Caused It? How Can We Stop It?
by Zoe Harcombe (Author)
The Obesity Epidemic: What caused it? How can we stop it? does what it says in the title it answers those two critical questions. It takes you on the journey that the author, Zoë Harcombe went on to answer those questions and hopefully it will shock you as much as it shocked her. The starting point must be when did The Obesity Epidemic start? The graphs and tables show a stunning increase in obesity levels at the turn of the 1980 s and obesity literally takes off, like an aeroplane trajectory, from that point onwards. Obesity in the UK, as an example, increases almost 10 fold between the 1970 s and 1999 from 2.7% to 25%. So what happened? The short answer is we changed our diet advice. More accurately we did a U-turn in our diet advice. We used to believe (and our grandmothers...
|

|
The Evolution of Obesity
by Michael L. Power (Author), Jay Schulkin (Author)
In this sweeping exploration of the relatively recent obesity epidemic, Michael L. Power and Jay Schulkin probe evolutionary biology, history, physiology, and medical science to uncover the causes of our growing girth. The unexpected answer? Our own evolutionary success.For most of the past few million years, our evolutionary ancestors' survival depended on being able to consume as much as possible when food was available and to store the excess energy for periods when it was scarce. In the developed world today, high-calorie foods are readily obtainable, yet the propensity to store fat is part of our species' heritage, leaving an increasing number of the world's people vulnerable to obesity. In an environment of abundant food, we are anatomically, physiologically, metabolically, and...
|

|
The Obesity Cure: Weight Control, Metabolic Health, Revitalized Youth With Power Amino Acids
by NovaLife
At last, a breakthrough in nutritional science that identifies both the cause and solution of obesity, America's #1 metabolic disease. Using a lifetime of scientific achievement and clinical insight, Nobel associate and author, Dr. George Scheele, explains how to use nature's gift--Power Amino Acids--to avoid "addictive taste disorders"? and harness the body's own feedback mechanisms to tame appetite, rebalance metabolism, and normalize body weight. In The Obesity Cure Dr. Scheele shows that obesity is only one in a spectrum of metabolic diseases associated with the Metabolic Syndrome and accelerated aging. He demonstrates how the current "paradoxes"? of obesity and metabolic health prove that something "essential"? is missing in our current understanding of nutritional health and weight...
|

|
My Journey Out Of Super Morbid Obesity
by Cindy Snyder (Author)
Cindy Snyder shares her deepest thoughts, feelings and experiences in this diary/journal in hopes to encourage others and for her to never forget where her God has brought her. Being warned by her physicians that her life was at stake, she knew she did not have the willpower to deliver herself from this bondage. This book is the personal journal of Cindy's journey out of obesity. You will be led through this journey as to what life is like for the super morbidly obese person and is filled with descriptive and explicit hardships that the super morbid obese must daily live with. Cindy has tried to be as open and honest as possible and in some instances very detailed and graphic as to what "life" had become. Cindy not only shares the battles but also lets everyone experience the victories...
|

|
Obesity Cancer & Depression: Their Common Cause & Natural Cure
by F. Batmanghelidj (Author)
This book, the result of over 20 years of research, looks at the conditions of obesity, cancer and depression through a new physiological perspective and offers a new approach in preventing and treating these conditions
|

|
Weighing In: Obesity, Food Justice, and the Limits of Capitalism (California Studies in Food and Culture)
by Julie Guthman (Author)
Weighing In takes on the "obesity epidemic," challenging many widely held assumptions about its causes and consequences. Julie Guthman examines fatness and its relationship to health outcomes to ask if our efforts to prevent "obesity" are sensible, efficacious, or ethical. She also focuses the lens of obesity on the broader food system to understand why we produce cheap, over-processed food, as well as why we eat it. Guthman takes issue with the currently touted remedy to obesity--promoting food that is local, organic, and farm fresh. While such fare may be tastier and grown in more ecologically sustainable ways, this approach can also reinforce class and race inequalities and neglect other possible explanations for the rise in obesity, including environmental toxins. Arguing that ours is...
|

|
Food Fight: The Inside Story of The Food Industry, America's Obesity Crisis, and What We Can Do About It
by Kelly Brownell (Author), Katherine Battle Horgen (Author)
"The evergreen subject of American gluttony and sloth brings out the best in scientist-advocates, and the authors, while drawing on a mountain of statistics and studies, make their indictment both funny and appalling." --Publishers Weekly "Brownell and Horgen uncover some of America's biggest diet hazards and how to avoid them." --Self magazine "This is a fascinating, empowering must-read filled with practical ways to take action." --Shape magazine "Food Fight is . . . an important contribution to the discourse around the obesity epidemic. I highly recommend it to anyone who wishes to learn more about the role of the food industry, and especially to public health advocates looking for clearly presented research and ideas for positive change." --Michele Simon, founder and...
|

|
Cognitive-Behavioral Treatment of Obesity: A Clinician's Guide
by Zafra Cooper (Author), Christopher G. Fairburn (Author), Deborah M. Hawker (Author)
The first cognitive-behavioral treatment manual for obesity, this volume presents an innovative therapeutic model currently being evaluated in controlled research at Oxford University. From leading clinical researchers, the approach is specifically designed to overcome a major weakness of existing therapies: posttreatment weight regain. The book details powerful ways to help patients not only to achieve weight loss, but also to modify the problematic cognitions that undermine long-term weight control. Drawing on strategies proven effective with such problems as binge eating, the manual contains everything needed to implement the treatment: intervention guidelines, case examples, and reproducible handouts and forms.
|

|
Fat Politics: The Real Story behind America's Obesity Epidemic
by J. Eric Oliver (Author)
It seems almost daily we read newspaper articles and watch news reports exposing the growing epidemic of obesity in America. Our government tells us we are experiencing a major health crisis, with sixty percent of Americans classified as overweight, and one in four as obese. But how valid are these claims? In Fat Politics, J. Eric Oliver shows how a handful of doctors, government bureaucrats, and health researchers, with financial backing from the drug and weight-loss industries, have campaigned to create standards that mislead the public. They mislabel more than sixty million Americans as "overweight," inflate the health risks of being fat, and promote the idea that obesity is a killer disease. In reviewing the scientific evidence, Oliver shows there is little proof that obesity...
|

|
Fed Up!: Winning the War Against Childhood Obesity
by Susan Okie (Author)
Obesity now ranks second only to smoking as a wholly preventable cause of death. It is a major contributor to heart disease, high blood pressure, high cholesterol, and depression. Even conservative estimates show that 20 per cent of all children are now considered to be overweight - worldwide there are 22 million kids under five years old that are defined as fat. Eating way too much unhealthy food coupled with lifestyles that don't involve a lot of physical activity accounts for a lot of what's making our children heavier. But that's not the whole story. Researchers are at a loss to explain why obesity rates have risen so suddenly and so steeply. "Fed Up!", based in part on the Institute of Medicine's ground-breaking report on childhood obesity, and written by paediatrician and...
|
|